Responses
Gestational Trophoblastic Neoplasia
Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group–174 Phase III Trial
Compose a Response to This Article
Other responses
No responses have been published for this article.